Health and Healthcare

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

1281 Articles

Jon C. Ogg | Sep 26, 2016 at 10:50 AM EDT

New Crohn’s Disease Drug Approved by FDA

A unit of Johnson & Johnson has announced that the FDA has approved its Stelara for the treatment of moderately…

Chris Lange | Sep 13, 2016 at 10:25 AM EDT

Jefferies Issues Top Pharma and Biohealth Stocks to Buy

Despite recent market headwinds and volatility, there are strong underlying fundamentals among the large cap pharmaceuticals that are continuing to…

Chris Lange | Sep 2, 2016 at 7:40 AM EDT

8 Major FDA Decisions and Trial Results to Watch for in September

24/7 Wall St. has collected several big FDA decisions and mid-to-late-stage trials that should be coming up in September.

Paul Ausick | Aug 22, 2016 at 4:01 PM EDT

Apple, J&J Weigh on DJIA Monday

August 22, 2016: Markets opened lower again Monday as investors remain cautious ahead of the Fed’s Jackson Hole conference beginning…

Jon C. Ogg | Jul 20, 2016 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Johnson & Johnson, Lockheed Martin, MGIC Investment, TransCanada, Verizon and More

The top analyst upgrades, downgrades and initiations seen on Wednesday morning include Johnson & Johnson, Lockheed Martin, MGIC Investment, TransCanada…

Paul Ausick | Jul 19, 2016 at 4:01 PM EDT

McDonald’s, J&J Buoy DJIA on Tuesday

July 19, 2016: Markets opened mixed on Tuesday with the blue chips opening lower before bouncing higher. Unlike the S&P…

Chris Lange | Jul 19, 2016 at 9:25 AM EDT

Johnson & Johnson Offers Q2 Earnings Beat, Rosy Guidance

As one of the largest health care companies on the market, Johnson & Johnson helps set a direction for the…

Chris Lange | Jul 18, 2016 at 10:25 AM EDT

What to Look for in Johnson & Johnson Earnings

Johnson & Johnson is set to release its second-quarter earnings report before the markets open on Tuesday, a period in…

Chris Lange | Jul 17, 2016 at 10:15 AM EDT

Top Dow Earnings for the Week Ahead

One-third of the 30 Dow stocks are reporting quarterly results between July 18 and 22. The main question is whether…

Chris Lange | Jul 14, 2016 at 9:15 AM EDT

How DJIA Earnings Could Make or Break This Rally

With the Dow Jones Industrial Average hitting new all-time highs this past week, we have to wonder what we have…

Chris Lange | Jul 3, 2016 at 6:30 AM EDT

The Top 5 Performing Dow Stocks Coming Out of the Brexit

Looking at what was a brief but massive fallout within broad markets, we are realizing that the Brexit provided a…

Steven M. Peters | Jun 24, 2016 at 11:15 AM EDT

The Largest Company in Every State

America’s largest companies tend to be located in major metropolitan areas. New York City alone is home to the headquarters…

Jon C. Ogg | Jun 23, 2016 at 8:05 AM EDT

20 Companies Buying Back the Most Stock in 2016

Standard & Poor's has now shown that the first quarter of 2016 saw a 12% rise in buyback spending to…

Thomas Frohlich | Jun 9, 2016 at 2:32 PM EDT

The 50 Highest Rated CEOs

Top executives, CEOs especially, are often measured by the business decisions they make and how their company is performing. Often…

Chris Lange | Jun 6, 2016 at 1:40 PM EDT

How Credit Suisse Views Major Pharma After ASCO

The ASCO annual meeting is absolutely making waves in the pharmaceutical industry. As a result, analysts are giving their two…

1 … 44 45 46 47 48 … 86

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

New Crohn’s Disease Drug Approved by FDA

Jefferies Issues Top Pharma and Biohealth Stocks to Buy

8 Major FDA Decisions and Trial Results to Watch for in September

Apple, J&J Weigh on DJIA Monday

Top Analyst Upgrades and Downgrades: Johnson & Johnson, Lockheed Martin, MGIC Investment, TransCanada, Verizon and More

McDonald’s, J&J Buoy DJIA on Tuesday

Johnson & Johnson Offers Q2 Earnings Beat, Rosy Guidance

What to Look for in Johnson & Johnson Earnings

Top Dow Earnings for the Week Ahead

How DJIA Earnings Could Make or Break This Rally

The Top 5 Performing Dow Stocks Coming Out of the Brexit

The Largest Company in Every State

20 Companies Buying Back the Most Stock in 2016

The 50 Highest Rated CEOs

How Credit Suisse Views Major Pharma After ASCO

Google vs Apple: Which of the 2 Biggest AI Stocks Is the Better Buy Right Now?

The 20% Tax Credit Developers Use to Flip Historic Buildings and How You Can Claim It

Your RV Qualifies for the Same Mortgage Interest Deduction as a House, but Most Owners Never Claim It

The 20% Tax Credit Developers Use to Flip Historic Buildings and How You Can Claim It

Your RV Qualifies for the Same Mortgage Interest Deduction as a House, but Most Owners Never Claim It

Google vs Apple: Which of the 2 Biggest AI Stocks Is the Better Buy Right Now?

The 20% Tax Credit Developers Use to Flip Historic Buildings and How You Can Claim It

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

New Crohn’s Disease Drug Approved by FDA

Jefferies Issues Top Pharma and Biohealth Stocks to Buy

8 Major FDA Decisions and Trial Results to Watch for in September

Apple, J&J Weigh on DJIA Monday

Top Analyst Upgrades and Downgrades: Johnson & Johnson, Lockheed Martin, MGIC Investment, TransCanada, Verizon and More

McDonald’s, J&J Buoy DJIA on Tuesday

Johnson & Johnson Offers Q2 Earnings Beat, Rosy Guidance

What to Look for in Johnson & Johnson Earnings

Top Dow Earnings for the Week Ahead

How DJIA Earnings Could Make or Break This Rally

The Top 5 Performing Dow Stocks Coming Out of the Brexit

The Largest Company in Every State

20 Companies Buying Back the Most Stock in 2016

The 50 Highest Rated CEOs

How Credit Suisse Views Major Pharma After ASCO

Google vs Apple: Which of the 2 Biggest AI Stocks Is the Better Buy Right Now?

The 20% Tax Credit Developers Use to Flip Historic Buildings and How You Can Claim It

Your RV Qualifies for the Same Mortgage Interest Deduction as a House, but Most Owners Never Claim It

Featured Reads

The 20% Tax Credit Developers Use to Flip Historic Buildings and How You Can Claim It

Your RV Qualifies for the Same Mortgage Interest Deduction as a House, but Most Owners Never Claim It